Chevy Chase Trust’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,758
Closed -$6.82M 659
2022
Q3
$6.82M Buy
27,758
+243
+0.9% +$65.6K 0.03% 444
2022
Q2
$6.81M Buy
27,515
+149
+0.5% +$40.2K 0.03% 455
2022
Q1
$9.06M Buy
27,366
+81
+0.3% +$24.9K 0.03% 435
2021
Q4
$9.8M Sell
27,285
-579
-2% -$196K 0.03% 423
2021
Q3
$9.07M Sell
27,864
-999
-3% -$338K 0.03% 427
2021
Q2
$9.01M Sell
28,863
-1,493
-5% -$458K 0.03% 437
2021
Q1
$9.68M Sell
30,356
-2,411
-7% -$772K 0.03% 424
2020
Q4
$10.6M Sell
32,767
-635
-2% -$176K 0.04% 395
2020
Q3
$9.26M Sell
33,402
-2,782
-8% -$801K 0.04% 385
2020
Q2
$8.74M Sell
36,184
-1,276
-3% -$256K 0.04% 398
2020
Q1
$5.44M Sell
37,460
-272
-0.7% -$45.2K 0.03% 438
2019
Q4
$6.44M Buy
37,732
+761
+2% +$141K 0.02% 487
2019
Q3
$6.58M Sell
36,971
-729
-2% -$158K 0.03% 471
2019
Q2
$9.82M Buy
37,700
+72
+0.2% +$19.1K 0.04% 405
2019
Q1
$10.4M Buy
37,628
+538
+1% +$179K 0.04% 397
2018
Q4
$12.1M Buy
37,090
+222
+0.6% +$77.1K 0.06% 318
2018
Q3
$16.6M Buy
36,868
+1,296
+4% +$511K 0.07% 292
2018
Q2
$14.6M Buy
+35,572
New +$12.9M 0.06% 320

Other funds holding ABMD

Chevy Chase Trust's ABMD Position: Q4 2022 in Review

Chevy Chase Trust sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 27,758 shares — an estimated $6.82M sold.

Chevy Chase Trust first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $16.6M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Chevy Chase Trust reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Chevy Chase Trust sold 27,758 Abiomed Inc shares in Q4 2022, an estimated $6.82M.
  • Chevy Chase Trust first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • Chevy Chase Trust's Abiomed Inc position peaked at $16.6M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Chevy Chase Trust's 13F filing for Q4 2022, filed 9 Feb 2023.